EUVIMEDScopri EUVIMED
Crossref

Effect of the Phosphoryl Guanidine Modification in Chimeric DNA–RNA crRNAs on the Activity of the CRISPR-Cas9 System In Vitro

Daria V Prokhorova iD, Maxim S Kupryushkin, Sergey A Zhukov, Timofey D Zharkov, Ilya S Dovydenko, Kristina I Yakovleva iD, Ivan M Pereverzev, Anastasiya M Matveeva, Dmitriy V Pyshnyi iD, Grigory A Stepanov

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.4c00147 ↗

At a glance

Journal article in ACS Chemical Biology, 2024. Written by Daria V Prokhorova and 9 co-authors. Institution: Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Lavrentiev Avenue 8, Novosibirsk 63…. Major MEDLINE topics: CRISPR-Cas Systems, DNA, Gene Editing, Guanidine. Cited 7 times so far (Crossref); 46 references. Funded by: Russian Science Foundation, Siberian Branch, Russian Academy of Sciences.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Currently, the CRISPR-Cas9 system serves as a prevalent tool for genome editing and gene expression regulation. Its therapeutic application is limited by off-target effects that can affect genomic integrity through nonspecific, undesirable changes in the genome. Various strategies have been explored to mitigate the off-target effects. Many approaches focus on modifying components of the system, namely, Cas9 and guide RNAs, to enhance specificity. However, a common challenge is that methods aiming to increase specificity often result in a significant reduction in the editing efficiency. Here, we introduce a novel approach to modifying crRNA to balance CRISPR-Cas9 specificity and efficiency. Our approach involves incorporating nucleoside modifications, such as replacing ribo- to deoxyribonucleosides and backbone modifications, using phosphoryl guanidine groups, specifically 1,3-dimethylimidazolidin-2-ylidene phosphoramidate. In this case, within the first 10 nucleotides from the 5' crRNA end, phosphodiester bonds are substituted with phosphoryl guanidine groups. We demonstrate that crRNAs containing a combination of deoxyribonucleosides and single or multiple phosphoryl guanidine groups facilitate the modulation of CRISPR-Cas9 system activity while improving its specificity in vitro.

Subjects

MeSH terms (MEDLINE)

CRISPR-Cas SystemsDNAGene EditingGuanidineRNA, Guide, CRISPR-Cas SystemsRNAHumansGuanidines

Substances

DNAGuanidineRNA, Guide, CRISPR-Cas SystemsRNAGuanidines

Authors and institutions

  • Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Lavrentiev Avenue 8, Novosibirsk 630090, Russia.

ORCID profiles: Daria V Prokhorova, Kristina I Yakovleva, Dmitriy V Pyshnyi

Funding

  • Russian Science Foundation
  • Siberian Branch, Russian Academy of Sciences

Cite

APA

Prokhorova, D. V., Kupryushkin, M. S., Zhukov, S. A., Zharkov, T. D., Dovydenko, I. S., Yakovleva, K. I., Pereverzev, I. M., Matveeva, A. M., Pyshnyi, D. V., & Stepanov, G. A. (2024). Effect of the Phosphoryl Guanidine Modification in Chimeric DNA–RNA crRNAs on the Activity of the CRISPR-Cas9 System In Vitro. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00147

Vancouver

Prokhorova DV, Kupryushkin MS, Zhukov SA, Zharkov TD, Dovydenko IS, Yakovleva KI, et al. Effect of the Phosphoryl Guanidine Modification in Chimeric DNA–RNA crRNAs on the Activity of the CRISPR-Cas9 System In Vitro. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00147

BibTeX
@article{Prokhorova2024,
  author = {Prokhorova, Daria V and Kupryushkin, Maxim S and Zhukov, Sergey A and Zharkov, Timofey D and Dovydenko, Ilya S and Yakovleva, Kristina I and Pereverzev, Ivan M and Matveeva, Anastasiya M and Pyshnyi, Dmitriy V and Stepanov, Grigory A},
  title = {Effect of the Phosphoryl Guanidine Modification in Chimeric DNA–RNA crRNAs on the Activity of the CRISPR-Cas9 System In Vitro},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.4c00147}
}
Start for free →